FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Flachenecker

Research Profile

Disorders

Procedures

Anatomy

Chemicals & Drugs

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Peter Flachenecker
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany.
Anke Stroet; Uwe Zettl; Andreas Ziegler; Frauke Zipp; Paul Friedemann; Jan Dörr; Peter Flachenecker; Vinzenz Fleischer; Ralf Gold; Claudia Hemmelmann; Bernd C Kieseier; Holger Nückel; Friedmann Paul; Michaela Starck; Andrew Chan
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Peter Flachenecker
Autoimmune diseases and rehabilitation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Flachenecker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Peter Flachenecker
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany.
Expert review of neurotherapeutics 2013;13(3 Suppl 1):15-9.
2012: Anke Stroet; Uwe Zettl; Andreas Ziegler; Frauke Zipp; Paul Friedemann; Jan Dörr; Peter Flachenecker; Vinzenz Fleischer; Ralf Gold; Claudia Hemmelmann; Bernd C Kieseier; Holger Nückel; Friedmann Paul; Michaela Starck; Andrew Chan
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Therapeutic advances in neurological disorders 2012;5(2):75-9.
2012: Peter Flachenecker
Autoimmune diseases and rehabilitation.
Autoimmunity reviews 2012;11(3):219-25.
2010: Peter Flachenecker; Laura Khil; Sverrir Bergmann; Mariusz Kowalewski; Ion Pascu; Francisco Carlos Pérez-Miralles; Jaume Sastre-Garriga; Thomas Zwingers
Development and pilot phase of a European MS register.
Journal of neurology 2010;257(10):1620-7.
2009: Kristin Stuke; Peter Flachenecker; Uwe K Zettl; Wolfgang G Elias; Matthias Freidel; Judith Haas; Dorothea Pitschnau-Michel; Sebastian Schimrigk; Peter Rieckmann
Symptomatology of MS: results from the German MS Registry.
Journal of neurology 2009;256(11):1932-5.
2008: Peter Flachenecker; Kristin Stuke
National MS registries.
Journal of neurology 2008;255 Suppl 6():102-8.
2008: Peter Flachenecker; Heike Meissner
Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(2):274-7.
2008: Peter Flachenecker; Kristin Stuke; Wolfgang Elias; Matthias Freidel; Judith Haas; Dorothea Pitschnau-Michel; Sebastian Schimrigk; Uwe K Zettl; Peter Rieckmann
Multiple sclerosis registry in Germany: results of the extension phase 2005/2006.
Deutsches Ärzteblatt international 2008;105(7):113-9.
2007: Peter Flachenecker
Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosis.
Journal of neurology 2007;254 Suppl 2():II96-101.
2006: Peter Flachenecker
Epidemiology of neuroimmunological diseases.
Journal of neurology 2006;253 Suppl 5():V2-8.
2005: Peter Flachenecker; Karlheinz Reiners
Abnormal baroreflex responses in multiple sclerosis.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2005;15(6):419; author reply 420.
2005: Stefan M Gold; David C Mohr; Inge Huitinga; Peter Flachenecker; Esther M Sternberg; Christoph Heesen
The role of stress-response systems for the pathogenesis and progression of MS.
Trends in immunology 2005;26(12):644-52.
2005: Marcus Beck; Peter Flachenecker; Tim Magnus; Ralf Giess; Karlheinz Reiners; Klaus V Toyka; Markus Naumann
Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF.
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 2005;6(2):100-3.
2005: Michaela Gottschalk; Tania Kümpfel; Peter Flachenecker; Manfred Uhr; Claudia Trenkwalder; Florian Holsboer; Frank Weber
Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.
Archives of neurology 2005;62(2):277-80.
2004: Peter Flachenecker; Peter Rieckmann
Health outcomes in multiple sclerosis.
Current opinion in neurology 2004;17(3):257-61.
2004: Peter Flachenecker
Disease-modifying drugs for the early treatment of multiple sclerosis.
Expert review of neurotherapeutics 2004;4(3):455-63.
2004: Peter Flachenecker; Irene Bihler; F Weber; M Gottschalk; Klaus V Toyka; Peter Rieckmann
Cytokine mRNA expression in patients with multiple sclerosis and fatigue.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(2):165-9.
2004: Boris-A Kallmann; Judith Sauer; Mira Schliesser; Monika Warmuth-Metz; Peter Flachenecker; Georg Becker Dagger; Peter Rieckmann; Mathias Mäurer
Determination of ventricular diameters in multiple sclerosis patients with transcranial sonography (TCS)--a two year follow-up study.
Journal of neurology 2004;251(1):30-4.
2003: Peter Flachenecker; A Rufer; I Bihler; C Hippel; Karlheinz Reiners; Klaus V Toyka; J Kesselring
Fatigue in MS is related to sympathetic vasomotor dysfunction.
Neurology 2003;61(6):851-3.
2003: Peter Flachenecker; Christiane Schneider; Simone Cursiefen; Kenneth Ricker; Klaus V Toyka; Karlheinz Reiners
Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM).
Neuromuscular disorders : NMD 2003;13(4):289-93.
2003: Peter Flachenecker; Peter Rieckmann
Early intervention in multiple sclerosis : better outcomes for patients and society?
Drugs 2003;63(15):1525-33.
2003: VI Leussink; Peter Flachenecker; Dirk Brechtelsbauer; Martin Bendszus; U Sliwka; Ralf Gold; Georg Becker
Superficial siderosis of the central nervous system: pathogenetic heterogeneity and therapeutic approaches.
Acta neurologica Scandinavica 2003;107(1):54-61.
2002: Peter Flachenecker; Tania Kümpfel; Boris-A Kallmann; M Gottschalk; Oliver Grauer; Peter Rieckmann; Claudia Trenkwalder; Klaus V Toyka
Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(6):523-6.
2002: Philipp Sand; T Mori; C Godau; Gerald Stöber; Peter Flachenecker; Petra Franke; Markus M Nöthen; Jürgen Fritze; Wolfgang Maier; Klaus-Peter Lesch; Peter Riederer; Helmut Beckmann; Jürgen Deckert
Norepinephrine transporter gene (NET) variants in patients with panic disorder.
Neuroscience letters 2002;333(1):41-4.
2002: Peter Flachenecker; Stefan Jung; Peter Rieckmann; Klaus V Toyka
sICAM-1 is not a marker for disease activity in the relapse-free interval of multiple sclerosis--a cross-sectional pilot study.
Journal of neurology 2002;249(8):1001-3.
2001: Peter Flachenecker; Karlheinz Reiners; M Krauser; A Wolf; Klaus V Toyka
Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(5):327-34.
2001: Peter Flachenecker; Klaus V Toyka; Karlheinz Reiners
[Cardiac arrhythmias in Guillain-Barre syndrome. An overview of the diagnosis of a rare but potentially life-threatening complication].
Der Nervenarzt 2001;72(8):610-7.
2000: Peter Flachenecker; K V Toyka
[Early diagnosis of multiple sclerosis].
Versicherungsmedizin / herausgegeben von Verband der Lebensversicherungs-Unternehmen e.V. und Verband der Privaten Krankenversicherung e.V 2000;52(3):119-24.
2000: Peter Flachenecker; K Lem; Wolfgang Müllges; Karlheinz Reiners
Detection of serious bradyarrhythmias in Guillain-Barré syndrome: sensitivity and specificity of the 24-hour heart rate power spectrum.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2000;10(4):185-91.
2000: Simone Cursiefen; Peter Flachenecker; Klaus V Toyka; Peter Rieckmann
Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis.
European neurology 2000;43(3):186-7.
1999: Simone Cursiefen; Peter Flachenecker; Peter Rieckmann; Klaus V Toyka
[Mitoxantrone (Novantron) in therapy of severe multiple sclerosis. A retrospective study of 15 patients].
Der Nervenarzt 1999;70(8):723-31.
1999: Peter Flachenecker; A Wolf; M Krauser; Hans-Peter Hartung; Karlheinz Reiners
Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance.
Journal of neurology 1999;246(7):578-86.
1999: Peter Flachenecker; Karlheinz Reiners
Twenty-four-hour heart rate power spectrum for evaluation of autonomic dysfunction in Guillain-Barré syndrome.
Journal of the neurological sciences 1999;165(2):144-53.
1999: Peter Flachenecker; M Janka; Roland Goldbrunner; Klaus V Toyka
Clinical outcome of sural nerve biopsy: a retrospective study.
Journal of neurology 1999;246(2):93-6.
1998: I Bergmann; M Dauphin; Markus Naumann; Peter Flachenecker; Wolfgang Müllges; Martin Koltzenburg; Claudia Sommer
Selective degeneration of sudomotor fibers in Ross syndrome and successful treatment of compensatory hyperhidrosis with botulinum toxin.
Muscle & nerve 1998;21(12):1790-3.
1998: Peter Flachenecker; Karlheinz Reiners
Autonomic nervous system testing.
Muscle & nerve 1998;21(5):680.
1998: Peter Flachenecker; Behrouz Mansouri Taleghani; Ralf Gold; Ralf Grossmann; D Wiebecke; Klaus V Toyka
Treatment of severe myasthenia gravis with protein A immunoadsorption and cyclophosphamide.
Transfusion science 1998;19 Suppl():43-6.
1997: Peter Flachenecker; Hans-Peter Hartung; Karlheinz Reiners
Power spectrum analysis of heart rate variability in Guillain-Barré syndrome. A longitudinal study.
Brain : a journal of neurology 1997;120 ( Pt 10)():1885-94.
1997: Peter Flachenecker; P Wermuth; Hans-Peter Hartung; Karlheinz Reiners
Quantitative assessment of cardiovascular autonomic function in Guillain-Barre syndrome.
Annals of neurology 1997;42(2):171-9.
1997: M Naumann; Peter Flachenecker; E B Bröcker; K V Toyka; Karlheinz Reiners
Botulinum toxin for palmar hyperhidrosis.
Lancet 1997;349(9047):252.
1997: Peter Flachenecker; R Kiefer; Markus Naumann; M Handwerker; Heinz Reichmann
Distal muscular dystrophy of Miyoshi type. Report of two cases and review of the literature.
Journal of neurology 1997;244(1):23-9.
1996: Peter Flachenecker; Wolfgang Müllges; P Wermuth; Hans-Peter Hartung; Karlheinz Reiners
Eyeball pressure testing in the evaluation of serious bradyarrhythmias in Guillain-Barré syndrome.
Neurology 1996;47(1):102-8.
1996: Peter Flachenecker; Hans-Peter Hartung
[Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].
Der Nervenarzt 1996;67(6):444-51.
1996: Peter Flachenecker; Hans-Peter Hartung
[Course of illness and prognosis of multiple sclerosis. 1: The natural illness course].
Der Nervenarzt 1996;67(6):435-43.
1996: Peter Flachenecker; Hans-Peter Hartung
[EDMUS--a new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the "European Concentrated Action for Multiple Sclerosis"].
Der Nervenarzt 1996;67(4):277-82.
1995: Peter Flachenecker; Klaus V Toyka; Hans-Peter Hartung
[Active vaccinations in multiple sclerosis].
Deutsche medizinische Wochenschrift (1946) 1995;120(44):1513-6.
1995: Peter Flachenecker; Hans-Peter Hartung
[Multiple sclerosis and pregnancy. Overview and status of the European multicenter PRIMS study].
Der Nervenarzt 1995;66(2):97-104.